CTRI/2022/06/043290尚未招募2/3 期
Study OF Etiology , Clinical profile , Complications And Outcome in patients of Acute Kidney Injury
Dr AFFAN ALI KHAN1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2022年6月29日最近更新:
试验速览
- 阶段
- 2/3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- All cause mortality
研究概览
简要总结
the present study is the clinical observational study for completion under DR DY PATIL deemed to be university
total duration of trial is 1 year
TITLE : STUDY of Etiology , Clinical profile , Complications and Outcome in Patients of acute kidney injury
STUDY GROUP : Sample size 200
STUDY CENTER : School of medicine Dr. DY PATIL deemed to be university and hospital , nerul , navimumbai
PG scholar : DR. AFFAN ALI KHAN
GUIDE : DR. RAVINDRA NATH SAHAY
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18.00 Year(s) 至 80.00 Year(s)（—）
- 性别
- All
入选标准
- •1.Patients with Acute Kidney Injury clinically diagnosed when the serum Creatinine increases to more than 2 mg/100 ml with or without oliguria 2.Patients with steady increase in serum Creatinine concentration of atleast 1 mg/ 100 ml over 48 hours 3.Patients with an increase in serum Creatinine by more than 20 % per day if baseline is more than 2.5 mg/100 ml.
排除标准
- •1.Patients less than 18 years of age 2.Patients with previous Renal transplantation 3.Patients with evidence of Contracted Kidneys on ultrasound scan of abdomen.
结局指标
主要结局
All cause mortality
时间窗: 1 year
次要结局
- Percentage of cases which progressed to chronic kidney disease(10 months)
研究者
研究点 (1)
Loading locations...
相似试验
尚未招募
不适用
A study on incidence of strokeCTRI/2022/10/046712Dr Panchami Pradeep Kumar40
已完成
不适用
New Diabetes Mellitus and Pre-Diabetes With First-time Diagnosed Coronary Artery DiseaseDiabetesPreDiabetesCoronary Artery DiseaseNCT05208424Saud Al Babtain Cardiac Center300
已完成
不适用
Clinicopathologic Characteristics, Progression, and Prognostic Analysis of IPNBNCT06887023The First Hospital of Jilin University118
尚未招募
不适用
Study of the Causes, Clinical Profile and Outcome of Patients with Non-accidental ComaCTRI/2023/01/049257o Sponsor MD Dissertation
已完成
不适用
Characteristics of Disseminated Her2+ Breast Cancer Patients Treated With Trastuzumab That Have Reached Complete, Partial Remission or Stabilization of Disease During More Than 3 YearsHER-2 Positive Breast CancerNCT01433926Asociación para el Progreso de la Oncología en Málaga114